Cargando…

COVID-19 VACCINES AND ATRIAL FIBRILLATION RISK: A PHARMACOVIGILANCE ANALYSIS

Detalles Bibliográficos
Autores principales:	Kattubadi, Ayeesha, Solorzano, Juan, Feng, Katey, Brar, Vijaywant, Dominic, Paari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2022
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972584/ http://dx.doi.org/10.1016/S0735-1097(22)02829-7

Ejemplares similares

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH SEVERE COVID-19 DISEASE
por: Solorzano, Juan, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

ATRIAL FIBRILLATION IS ASSOCIATED WITH EARLY MORTALITY IN CRITICALLY ILL PATIENTS WITH COVID-19
por: Foster, Michael W., et al.
Publicado: (2022)

SEVERITY OF COVID-19 FURTHER INCREASES THE ODDS OF NEW-ONSET ATRIAL FIBRILLATION AND FLUTTER
por: Shah, Paras P., et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

PREVALENCE OF PRE-EXISTING ATRIAL FIBRILLATION AND ASSOCIATION WITH IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19
por: Sanders, David, et al.
Publicado: (2022)

THE IMPACT OF ORAL ANTICOAGULANTS ON THE OUTCOMES OF COVID-19 PATIENTS WITH A HISTORY OF HF AND ATRIAL FIBRILLATION
por: Zadeh, Ali Vaeli, et al.
Publicado: (2022)

EFFECT OF TOCILIZUMAB ON NEW ONSET ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS: AN UMBRELLA REVIEW
por: Patel, Aman, et al.
Publicado: (2022)

NEW-ONSET ATRIAL FIBRILLATION DURING HOSPITALIZATION FOR COVID-19 PATIENTS WITHOUT PREEXISTING CARDIOVASCULAR DISEASE
por: Wang, Suwei, et al.
Publicado: (2021)

IMPACT OF ATRIAL FIBRILLATION IN A PATIENT ADMITTED WITH COVID-19 INFECTION: A NATIONWIDE SAMPLE ANALYSIS
por: Ellis, John, et al.
Publicado: (2023)

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

RISK OF RECURRENT MYOCARDITIS FOLLOWING COVID-19 MRNA VACCINATION IN ADULTS WITH PRIOR HISTORY
por: Simone, Anthony, et al.
Publicado: (2022)

ATRIAL ARRHYTHMIAS ASSOCIATED WITH INCREASED MORBIDITY AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19
por: Bailey, Som Aftabi, et al.
Publicado: (2021)

A SYSTEMATIC REVIEW OF MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Dong, Vinh S., et al.
Publicado: (2022)

THE IMPLICATIONS OF COVID-19 VACCINATION ON HOSPITALIZATIONS AND CLINICAL OUTCOMES
por: Case, Brian, et al.
Publicado: (2022)

IMPACT OF COVID-19 VACCINATION AFTER ORTHOTOPIC HEART TRANSPLANTATION
por: Noor, Ahmed, et al.
Publicado: (2022)

VIRALVECTOR COVID19 VACCINE RELATED CONSTRICTIVE PERICARDITIS A CASE REPORT
por: Sadraldin, Rozana, et al.
Publicado: (2023)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

A SYSTEMATIC REVIEW AND META ANALYSIS OF THE EVIDENCE FROM THE PUBLISHED CASE REPORTS AND VACCINE ADVERSE EVENTS REPORTING SYSTEMS FOR THE MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Mehta, Ashwani, et al.
Publicado: (2022)

RISK PREDICTORS FOR MYOCARDIAL INJURY IN SEVERE COVID-19
por: Nascimento, Jorge H.P., et al.
Publicado: (2021)

A SYSTEMATIC REVIEW ON ECHOCARDIOGRAPHIC FINDINGS OF MYOCARDITIS AFTER THE SECOND COVID-19 MRNA VACCINATION DOSE
por: Elsayed, Sarah, et al.
Publicado: (2022)

CARDIAC COMPLICATIONS FOLLOWING REPEATED DOSES OF COVID-19 VACCINES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Le, Trang Thi Bich, et al.
Publicado: (2023)

AGE-BASED RISK FACTORS FOR SYMPTOMATIC COVID-19 IN THE MINORITY POPULATION
por: Gurbel, Paul A., et al.
Publicado: (2021)

IMPACT OF THROMBOPROPHYLACTIC STRATEGY ON BLEEDING RISK AMONG IN- AND OUTPATIENTS WITH COVID-19
por: Svet, Mark, et al.
Publicado: (2021)

IS HYPERTENSION (HTN) AN INDEPENDENT RISK FACTOR FOR MORTALITY IN COVID-19 PATIENTS?
por: Mughal, Mohsin, et al.
Publicado: (2021)

DOES ABO BLOOD GROUP INFLUENCE RISK OR SEVERITY OF COVID-19?
por: Anderson, Jeffrey L., et al.
Publicado: (2021)

HEALTH DISPARITIES INVOLVING HOSPITALIZATIONS AMONG COVID-19 VACCINATED CARDIOVASCULAR DISEASE PATIENTS INFECTED BY SARS-COV-2
por: Khodaverdi, M., et al.
Publicado: (2022)

INSIGHTS FROM THE CLINICAL PRESENTATION, DEMOGRAPHICS AND OUTCOME OF PATIENTS WITH COVID-19 VACCINE ASSOCIATED MYOCARDITIS: A SYSTEMATIC REVIEW
por: Fong, Lucas Chun Wah, et al.
Publicado: (2022)

RELATION OF 10-YEAR ASCVD RISK SCORE WITH SEVERE COVID-19 OUTCOMES
por: Arif, Yousif, et al.
Publicado: (2022)

PREDICTING COVID-19 INPATIENT MORTALITY AND MORBIDITY BY USING CARDIOVASCULAR RISK SCORES
por: Ahmed, Eyad, et al.
Publicado: (2021)

PERFORMANCE OF CURRENT THROMBOEMBOLISM RISK ASSESSMENT TOOLS IN PATIENTS WITH SEVERE COVID-19
por: Rios, Luis H. Paz, et al.
Publicado: (2021)

FORMER INCARCERATION AS A RISK FACTOR FOR COVID-19 ASSOCIATED SUDDEN DEATH
por: Raghunathan, Sahana, et al.
Publicado: (2022)

SOLUBLE P-SELECTIN, PLATELET ACTIVITY AND RISK OF MORBIDITY AND MORTALITY IN COVID-19
por: Mosarla, Ramya, et al.
Publicado: (2022)

OUTCOMES AND READMISSION RISK OF CRITICALLY ILL COVID-19 PATIENTS WITH CARDIOVASCULAR OUTCOMES
por: Manjappachar, Nirmala, et al.
Publicado: (2022)

COVID 19 M-RNA VACCINE ASSOCIATED MYOCARDITIS: A REPORT ON SHORT TERM FOLLOW UP CARDIAC IMAGING AND CLINICAL OUTCOMES
por: Ahmed, Taha, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

UTILITY OF AN AUTOMATED ARTIFICIAL INTELLIGENCE ECHOCARDIOGRAPHY SOFTWARE IN RISK STRATIFICATION OF HOSPITALIZED COVID-19 PATIENTS
por: Wang, Tom Kai Ming, et al.
Publicado: (2021)

RISK FACTORS OF ARTERIAL THROMBOEMBOLISM IN HOSPITALIZED COVID-19 PATIENTS: A MULTICENTER COHORT STUDY
por: Lee, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8310ci4kfjpreak7d4fcghsqi1